SPPI - Spectrum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5898.91M
Enterprise Value 3540.57M
Trailing P/E N/A
Forward P/E 1-6.00
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)8.22
Price/Book (mrq)3.28
Enterprise Value/Revenue 34.94
Enterprise Value/EBITDA 6-4.98

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -112.82%
Operating Margin (ttm)-125.34%

Management Effectiveness

Return on Assets (ttm)-21.49%
Return on Equity (ttm)-47.13%

Income Statement

Revenue (ttm)109.33M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)82.58M
EBITDA -108.59M
Net Income Avi to Common (ttm)-140.66M
Diluted EPS (ttm)-1.17
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)312.64M
Total Cash Per Share (mrq)2.84
Total Debt (mrq)3.92M
Total Debt/Equity (mrq)1.44
Current Ratio (mrq)4.84
Book Value Per Share (mrq)2.49

Cash Flow Statement

Operating Cash Flow (ttm)-75.71M
Levered Free Cash Flow (ttm)-8.46M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.83
52-Week Change 3-60.53%
S&P500 52-Week Change 33.91%
52 Week High 325.29
52 Week Low 36.22
50-Day Moving Average 39.62
200-Day Moving Average 310.80

Share Statistics

Avg Vol (3 month) 3903.06k
Avg Vol (10 day) 3960.46k
Shares Outstanding 5110.16M
Float 104.03M
% Held by Insiders 110.19%
% Held by Institutions 180.12%
Shares Short (Apr 30, 2019) 47.92M
Short Ratio (Apr 30, 2019) 410.58
Short % of Float (Apr 30, 2019) 48.44%
Short % of Shares Outstanding (Apr 30, 2019) 47.08%
Shares Short (prior month Mar 29, 2019) 47.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 28, 2012
Ex-Dividend Date 4Dec 18, 2012
Last Split Factor (new per old) 225/1
Last Split Date 3Sep 6, 2002